NCPA AWARD SPONSORED BY UPSHER-SMITH FOR TENTH CONSECUTIVE YEAR
Maple Grove, MN – October 11, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) is pleased to announce that James “Jim” Spoon DPh, an independent pharmacist with deep roots ... Read More
Exemestane Tablets, 25 mg Upsher-Smith Laboratories, LLC
Maple Grove, MN – October 11, 2017 – Upsher-Smith Laboratories, LLC. (Upsher-Smith) today announced the launch of Exemestane Tablets, 25 mg. The company recently received U.S. Food and Drug Administration (FDA) ... Read More
Osaka, Japan –September 21, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today received approvals from the Ministry of Health, Labour and Welfare (MHLW) for public knowledge-based applications1 for the ... Read More
Osaka, Japan –September 5, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today received approval of partial change applications by the Ministry of Health, Labour and Welfare (MHLW) for ARIPIPRAZOLE Tablets 3 mg ... Read More
Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP 2.5 mg/0.025 mg Upsher Smith Laboratories, LLC
Maple Grove, MN – August 31, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the
launch of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP, ... Read More
Osaka, Japan –August 15, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) received approvals by the Ministry of Health, Labour and Welfare for six compounds with 13 strengths of generic drugs. Among the six compounds, four compounds, Mirtazapine, Atomoxetine Hydrochloride, Tramadol Hydrochloride / Acetaminophen and Capecitabine, are approved for the first ... Read More
Maple Grove, MN – August 2, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has added another product to its growing generic portfolio, supporting its commitment to expanding and diversifying its product offerings. ... Read More
Offers Patients and Physicians a Fully Substitutable Generic Alternative with Brand-Quality Support
Vigadrone™ (vigabatrin) for Oral Solution, 500 mg. Upsher-Smith Laboratories, LLC
Maple Grove, MN – July 16, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch ... Read More
